In vivo and in vitro experiments indicate that circDB can promote HCC cell proliferation and reduce DNA damage by downregulating miR-34 expression and inhibiting USP7 (ubiquitin-specific protease 7)/Cyclin A2 activation [15]. Here, USP7 is linked to hepatocellular carcinoma.